Osaic Holdings
CARM

Osaic Holdings’s Carisma Therapeutics CARM Stock Holding History

Osaic Holdings’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-142
Closed -$29 – 7885
2025
Q3 		$29 Hold
142
– – ﹤0.01% 7813
2025
Q2 		$55 Hold
142
– – ﹤0.01% 7608
2025
Q1 		$44 Hold
142
– – ﹤0.01% 7296
2024
Q4 		$59 Hold
142
– – ﹤0.01% 7277
2024
Q3 		$139 Hold
142
– – ﹤0.01% 7218
2024
Q2 		$215 Hold
142
– – ﹤0.01% 7155
2024
Q1 		$322 Buy
142
+117
+468% +$281 ﹤0.01% 6896
2023
Q4 		$73 Hold
25
– – ﹤0.01% 7136
2023
Q3 		$105 Hold
25
– – ﹤0.01% 7225
2023
Q2 		$219 Sell
25
-1,000
-98% -$5.44K ﹤0.01% 7191
2023
Q1 		$3.18K Sell
1,025
-50
-5% -$476 ﹤0.01% 6537
2022
Q4 		$13K Sell
1,075
-458
-30% -$4.81K ﹤0.01% 5796
2022
Q3 		$14K Hold
1,533
– – ﹤0.01% 5819
2022
Q2 		$25K Sell
1,533
-2
-0.1% -$23 ﹤0.01% 5456
2022
Q1 		$18K Sell
1,535
-198
-11% -$2.77K ﹤0.01% 5752
2021
Q4 		$28K Sell
1,733
-100
-5% -$2.01K ﹤0.01% 5550
2021
Q3 		$29K Buy
1,833
+575
+46% +$27.6K ﹤0.01% 5504
2021
Q2 		$116K Buy
1,258
+508
+68% +$32.4K ﹤0.01% 4363
2021
Q1 		$39K Buy
750
+50
+7% +$2.36K ﹤0.01% 5042
2020
Q4 		$19K Buy
700
+600
+600% +$15.2K ﹤0.01% 5184
2020
Q3 		$3K Hold
100
– – ﹤0.01% 5706
2020
Q2 		$1K Hold
100
– – ﹤0.01% 5903
2020
Q1 		$1K Buy
+100
New +$1.64K ﹤0.01% 5804

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return

Osaic Holdings's CARM Position: Q4 2025 in Review

Osaic Holdings sold out of Carisma Therapeutics (CARM) in Q4 2025, closing a stake of 142 shares — an estimated $29 sold.

Osaic Holdings first reported a position in CARM in Q1 2020 and held it in 23 quarters. The position peaked at $116K in Q2 2021. 7 funds tracked by Wall St. Rank hold CARM as of Q4 2025.

  • Osaic Holdings reported no remaining Carisma Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 142 Carisma Therapeutics shares in Q4 2025, an estimated $29.
  • Osaic Holdings first reported a position in Carisma Therapeutics in Q1 2020 and held it in 23 quarters.
  • Osaic Holdings's Carisma Therapeutics position peaked at $116K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.